433
Views
43
CrossRef citations to date
0
Altmetric
Original Article

Does Early Physical Maturity Influence Breast Cancer Risk?

, &
Pages 171-176 | Received 18 Mar 1993, Accepted 22 Sep 1993, Published online: 08 Jul 2009

References

  • De Waard F, Trichopoulos D A. Unifying concept of the aetiology of breast cancer. Int J Cancer 1988; 41: 666–9
  • Bruning P F, Bonfrer J MG, van Noord P AH. Insulin resistance and breast cancer risk. Int J Cancer 1992; 52: 511–6
  • Secreto G, Toniolo P, Pisani P. Androgens and breast cancer in premenopausal women. Cancer Res 1989; 49: 471–6
  • Secreto G, Toniolo P, Berrino F. Serum and urinary androgens and risk of breast cancer in postmenopausal women. Cancer Res 1991; 51: 2572–6
  • Peyrat J P, Bonneterre J, Hecquet B. Plasma insulin-like growth factor l concentrations in human breast cancer. Eur J Cancer 1993; 29A: 492–7
  • Schapira D V, Kumar N B, Lyman G H, Cox C E. Abdominal obesity and breast cancer risk. Ann Intern Med 1990; 112: 182–6
  • Folsom A R, Kaye S A, Prineas P J. Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidem 1990; 131: 794–803
  • Berstein L M. Increased risk of breast cancer in women with central obesity; additional considerations. J Natl Cancer Inst 1990; 82: 1943–4
  • Ballard-Barbash R, Schatzkin A, Carter C L. Body fat distribution and breast cancer in the Framingham study. J Natl Cancer Inst 1990; 82: 286–90
  • Kodama M, Kodama T, Miura S, Yoshida M. Nutrition and breast cancer risk in Japan. Anticancer Res 1991; 11: 745–54
  • Moller D E, Flier J S. Insulin resistance; mechanisms, syndromes and implications. New Engl J Med 1991; 325: 838–48
  • De Ridder C M, Bruning P F, Zonderland M L. Body fat mass, body fat distribution and plasma hormones in early puberty in females. J Clin Endoc Metab 1990; 70: 888–93
  • Must A, Jacques P F, Dallal G E, Bajema C J, Dietz W H. Long term morbidity and mortality of overweight adolescents. N Engl J Med 1992; 327: 1350–5
  • Stoll B A, Secreto G. New hormone-related markers of high risk to breast cancer. Ann Oncol 1992; 3: 435–8
  • Ewertz M. Risk factors for breast cancer and their prognostic significance. Acta Oncol 1988; 27: 733–7
  • Preece M A. The trend to greater height and earlier maturation. Growth Matters 1989; 1: 3–4
  • De Waard F. Breast cancer incidence and nutritional status with particular reference to body weight and height. Cancer Res 1975; 35: 3351–6
  • Swanson C A, Jones D Y, Schatzkin A. Breast cancer risk assessed by anthropometry in the NHANES; epidemiologic follow-up study. Cancer Res 1988; 48: 5363–7
  • Törnberg S A, Holm L E, Carstensen J M. Breast cancer risk in relation to serum cholesterol, serum beta lipoprotein, height, weight and blood pressure. Acta Oncol 1988; 273: 31–7
  • Tretli S. Height and weight in relation to breast cancer morbidity and mortality; a prospective survey of 570 000 women in Norway. Int J Cancer 1989; 44: 23–30
  • London S J, Colditz G A, Stampfer M J. Prospective study of relative weight, height and risk of breast cancer. J Am Med Assoc 1989; 262: 2853–8
  • Vatten L J, Kvinnsland S. Body height and risk of breast cancer; a prospective study of 23 831 Norwegian women. Br J Cancer 1990; 61: 881–5
  • Karlberg J, Fryer J G, Engström J, Karlberg P. Analysis of linear growth using a mathematical model from 3–21 years. Acta Paediatr 1987, Suppl 337: 12–29
  • Vatten L J, Kvikstad A, Nymoen E H. Incidence and mortality of breast cancer related to body height and living conditions during childhood and adolescence. Eur J Cancer 1992; 28: 128–31
  • London S J, Willett W C. Relationship to diet and body size. Women at high risk to breast cancer, B A Stoll. Kluwer Acad, Dordrecht 1991; 57–72
  • Bowers C Y. A new dimension in the induced release of growth hormone in obese subjects. J Clin Endocrinol Metab 1993; 76: 817–8
  • De Waard F, Cornelis J P, Aoki K, Yoshida M. Breast cancer incidence according to weight and height in two cities in the Netherlands and in Aichi prefecture, Japan. Cancer 1977; 40: 1269–76
  • Yuasa S, MacMahon B. Lactation and reproductive histories of breast cancer patients in Tokyo, Japan. Bull World Health Organ 1970; 42: 195–204
  • Hoel D G, Wakabayashi T, Pike M C. Secular trends in the distribution of the breast cancer risk factors—menarche, first birth, menopause and weight in Hiroshima and Nagasaki, Japan. Am J Epidemiol 1983; 118: 78–89
  • Murata M, Kuno K, Sakamoto G. Epidemiology of family predisposition for breast cancer in Japan. J Natl Cancer Inst 1982; 69: 1229–34
  • Parkin D M, Nectoux J. Is female breast cancer increasing;. Approaches to breast cancer prevention, B A Stoll. Kluwer Acad, Dordrecht 1990; 15–33
  • Kurihara M, Aoki K, Tominaga S. Cancer mortality statistics in the world. Univ Nagoya, NagoyaJapan 1984
  • Frisch R E, McArthur J W. Menstrual cycles; fatness as a determinant of minimum weight for height necessary for their maintenance on onset. Science 1974; 185: 949–51
  • Frisch R E, Wyshak G, Albright N L. Lower lifetime occurrence of breast cancer and cancer of the reproductive system among former college athletes. Am J Clin Nutr 1987; 45: 328–35
  • Frisancho A R, Flegel P N. Advanced maturation with centripetal fat pattern. Hum Biol 1982; 54: 717–27
  • Rogol A D. Growth and growth hormone secretion at puberty; the role of gonadal steroid hormones. Acta Paediatr 1992, Suppl 383: 15–20
  • Delemarre van deWaal H A, Wennink J MB, Odink R JH. Gonadotrophin and growth hormone secretion throughout puberty. Acta Paediatr 1991, Suppl 372: 26–31
  • Martha P M, Reiter E O. Pubertal growth and growth hormone secretion. Endocrinol Metab Clin North Am 1991; 20: 165–82
  • Stanhope P, Pringle P J, Brook C GD. Mechanism of the adolescent growth spurt induced by low dose pulsatile GnRH treatment. Clin Endoc 1988; 28: 83–91
  • Preece M A, Pan H, Ratcliffe S G. Auxological aspects of male and female puberty. Acta Paediatr 1992, Suppl 383: 11–3
  • Albertsson-Wikland K, Romberg S, Isaksson Q, Westphal O. Secretory pattern of growth hormone in children of different growth rates. Acta Endocrinol 1983; 103(Supp 256)72–93
  • Hindmarsh P, Di Silvio L, Pringle P J. Changes in serum insulin concentration during puberty and their relationship to growth hormone. Clin Endocrinol 1988; 28: 381–8
  • Amiel S A, Caprio S, Sherwin P S. Insulin resistance of puberty. A defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab 1991; 72: 277–82
  • Rosenfield R L. Puberty and its disorders in girls. Endocrinol Metab Clin North Am 1991; 20: 15–42
  • Smith C P, Dunger D B, Williams A JK. Relationship between insulin, IGF1 and DHEAS concentrations during childhood, puberty and adult life. J Clin Endocrinol Metab 1989; 68: 932–7
  • Pescovitz O H. The endocrinology of the pubertal growth spurt. Acta Paediatr 1990, Suppl 367: 119–25
  • Mitamura R, Itoh Y, Suzuki N, Yano K, Okuno A. Changes in IGF1 and sex steroids during the pubertal growth spurt. Acta Paediatr 1992, Suppl 383: 99
  • Wilson D M, Killen J D, Hammer L D. IGF1 as a reflection of body composition, nutrition and puberty in sixth and seventh grade girls. J Clin Endocrinol Metab 1991; 73: 907–12
  • Garzo V G, Dorrington J H. Aromatase activity in human granulosa cells during follicular development and its modulation by FSH and by insulin. Am J Obstet Gynecol 1984; 148: 657–62
  • Barbieri R L, Makris A, Randall R V. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab 1986; 62: 904–10
  • Erickson G F, Garzo V G, Magoffin D A. IGF1 regulates aromatase activity in human granulosa and granulosa luteal cells. J Clin Endocrinol Metab 1989; 69: 716–24
  • Rochefort H, Garcia M. Estrogenic and antiestrogenic activities of androgens in female target tissues. Pharmacol Ther 1984; 23: 193–216
  • Hauner H. Physiology of the fat cell with emphasis on the role of growth hormone. Acta Paediatr 1992, Suppl 383: 47–51
  • Sherman B, Wallace R, Bean J, Schlabaugh L. Relationship of body weight to menarcheal and menopausal age: implications for breast cancer risk. J Clin Endocrinol Metab 1981; 52: 488–93
  • De Ridder C M, Thijssen J HH, Bruning P F, van den Brande J L, Zonderland M L, Erich W BM. Body fat mass, body fat distribution and pubertal development. J Clin Endocrinol Metab 1992; 75: 442–6
  • Aicardi G, Di Battista E, Vognolo M. IGFl trend in obese children and adolescents; comparison with normal subjects. Acta Paediatr 1991, Suppl 372: 159
  • Russo J H, Calaf G, Russo J. Hormones and proliferative activity in breast tissue. Approaches to breast cancer prevention, B A Stoll. Kluwer Academic, Dordrecht 1990; 35–51
  • Pieton-Martin S, Pike M C, Ross R K, Jones P A, Henderson B E. Increased cell division as a cause of human cancer. Cancer Res 1990; 50: 7415–21
  • Lippmann M E, Dickson P L, Gelmann E P. Growth-regulatory peptide production by human breast carcinoma cells. J Steroid Biochem 1988; 30: 53–61
  • Cullen K J, Smith H S, Hill S. Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions. Cancer Res 1991; 51: 4978–85
  • Darendeliler F, Hindmarsh P C, Preece M A. Growth hormone increases rate of pubertal maturation. Acta Endocrinol 1990; 122: 414–6
  • Merimee P J, Russell B, Quinn S, Riley W. Hormone and receptor studies: relationship to linear growth in childhood and puberty. J Clin Endocrinol Metab 1991; 73: 1031–7
  • Aubert M L. Control of onset of puberty. Growth Matters 1992; 10: 2–5
  • Cotterill A, Holly J, Savage M. Current status of the IGFs and their binding proteins. Growth Matters 1992; 9: 7–10
  • Pekonen F, Partanen S, Makinen T. Receptors for epidermal growth factors and insulin growth factor 1 and their relation to steroid receptors in human breast cancer. Cancer Res 1988; 48: 1343–7
  • Peyrat J P, Bonneterre J, Beuscart R. Insulin-like growth factor receptors in human breast cancer and their relation to estradiol and progesterone receptors. Cancer Res 1988; 48: 6429–33
  • Kaleko M, Rutter W J, Miller A D. Overexpression of the human IGFl receptor promotes ligand-dependent neoplastic transformation. Mol Cell Biol 1990; 10: 464–73
  • Stewart A J, Johnson M D, May F EB, Westley B R. Roles of IGFs and IGFl receptor in the estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem 1990; 265: 21172–8
  • Stoll B A. Breast cancer risk in Japanese women with special reference to the GH/IGF axis. Jpn J Clin Oncol 1992; 22: 1–5
  • Radimer K, Siskind V, Bain C, Schofield F. Relation between anthropometric indicators and risk of breast cancer among Australian women. Am J Epidemiol 1993; 138: 77–89
  • Björntorp P. Hormonal effects on fat distribution and its relationship to health risk factors. Acta Paediatr 1992, Suppl 383: 59–60
  • De Ridder C M, de Boer R W, Seidell J C. Body fat distribution in pubertal girls quantified by magnetic resonance imaging. Int J Obesity 1992; 16: 443–9
  • Deurenberg P. Methods for determining fat mass and fat distribution. Acta Paediatr 1992, Suppl 383: 53–7
  • Beex L VAM. Metabolic diseases influencing prognosis. Breast cancer; treatment and prognosis, B A Stoll. Blackwell Scientific, Oxford 1986; 200–11
  • Björntorp P. Abdominal obesity and the development of noninsulin dependent diabetes mellitus. Diabetes Metab Rev 1988; 4: 615–22

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.